HEMATOLOGICAL ONCOLOGY 期刊简介
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:
-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.
血液肿瘤学考虑发表有关造血和淋巴系统肿瘤疾病的实验和临床方面以及相关问题的文章。将基础科学应用于临床问题的转化研究尤其受到欢迎。鼓励涉及以下领域的手稿:
-血液肿瘤的临床实践和管理,包括: 急性和慢性白血病,恶性淋巴瘤,骨髓增生性疾病
-诊断研究,包括影像学和实验室检测
流行病学,血液病血液肿瘤的病理学和病理生物学
-治疗问题,包括1、2或3期试验以及同种异体和自体干细胞移植研究
-正常或患病的造血和淋巴细胞生成的细胞生物学,分子生物学,分子遗传学和细胞遗传学,包括干细胞,细胞因子和其他调节系统。审查材料的建议可以与主编讨论。只有在具有更广泛的科学或临床相关性的情况下,才会考虑收集病例材料和病例报告。
期刊ISSN
|
0278-0232 |
影响指数
|
5.218 |
最新CiteScore值
|
4.70 查看CiteScore评价数据 |
最新自引率
|
3.90% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
JOHN WILEY & SONS LTD, THE ATRIUM, SOUTHERN GATE, CHICHESTER, ENGLAND, W SUSSEX, PO19 8SQ |
偏重的研究方向(学科)
|
医学-血液学 |
出版周期
|
Quarterly |
出版年份
|
1983 |
出版国家/地区
|
ENGLAND |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
HEMATOLOGY(血液学)3区
ONCOLOGY(肿瘤学)3区
否
|
|||||
最新的影响因子
|
5.218 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 42 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
4.70
|
||||||||||||||||||
年文章数 | 110 | ||||||||||||||||||
SJR
|
0.918 | ||||||||||||||||||
SNIP
|
0.939 | ||||||||||||||||||
CiteScore排名
|
|
||||||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
Hematology-American Society of Hematology Education Program | 3.03 |
HEMOGLOBIN | 0.841 |
BIORHEOLOGY | 1.856 |
Blood Cancer Journal | 10.927 |
BLOOD | 21.892 |
LEUKEMIA | 11.413 |
Hematology | 2.246 |
HAEMOPHILIA | 4.244 |
TRANSFUSION | 3.125 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
Hematology-American Society of Hematology Education Program | 3.03 |
HAEMOPHILIA | 4.244 |
TRANSFUSION | 3.125 |
MICROCIRCULATION | 2.602 |
Blood Transfusion | 3.409 |
LEUKEMIA & LYMPHOMA | 3.247 |
THROMBOSIS RESEARCH | 3.905 |
ANNALS OF HEMATOLOGY | 3.636 |
HEMATOLOGICAL ONCOLOGY | 5.218 |
分享者 | 点评内容 |